Differences

This shows you the differences between two versions of the page.

--- en:start [2024/09/17 18:51]
Gianluca Frustagli "Nanoinnovation2024" and "AI for diagnostic imaging" events.
+++ en:start [2025/08/24 15:38] (current)
Gianluca Frustagli "Project GENEVAX": fixed link to logos.
@@ Line 12: / Line 12: @@
 The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers.
-{{map> :esagoni-eng.png?380|Core facilities}}
+{{map> :esagoni-eng.png?300|Core facilities}}
 /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */
-  * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 166,3,208,3,230,40,208,77,166,78,144,41]]
+  * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 124,100,175,100,201,144,176,189,125,189,99,145]]
-  * [[en:aree:ngs:start|Area Sequenziamento @ 308,84,351,84,372,121,351,158,308,158,287,122]]
+  * [[en:aree:ngs:start|Area Sequenziamento @ 209,53,260,52,286,97,261,141,209,141,185,97]]
-  * [[en:aree:fabiocell:start|Area FaBioCell @ 237,42,279,42,301,79,280,117,237,118,215,80]]
+  * [[en:aree:citometria:start|Area Citometria @ 210,149,261,149,286,193,261,238,210,238,185,193]]
-  * [[en:aree:citometria:start|Area Citometria @ 237,126,280,125,301,162,280,199,237,200,216,162]]
+  * [[en:aree:epr:start|Area EPR @ 125,197,176,197,201,241,176,286,125,285,100,242]]
-  * [[en:aree:epr:start|Area EPR @ 165,166,208,166,230,203,208,240,166,239,144,203]]
+  * [[en:aree:nmr:start|Area NMR @ 39,149,89,149,115,193,90,237,39,237,14,193]]
-  * [[en:aree:nmr:start|Area NMR @ 93,125,136,125,157,162,136,199,93,199,72,163]]
+  * [[en:aree:microscopia:start|Area Microscopia @ 98,48,124,3,174,3,200,47,174,92,124,91]]
-  * [[en:aree:microscopia:start|Area Microscopia @ 23,84,66,84,88,120,66,158,23,159,1,121]]
+  * [[en:aree:proteomica:start|Area Proteomica @ 39,51,90,51,116,94,91,139,39,139,14,95]]
-  * [[en:aree:proteomica:start|Area Proteomica @ 93,42,136,42,158,79,136,117,94,117,72,80]]
-  * [[en:aree:start|Aree @ 166,84,211,84,234,123,211,160,166,160,145,122]]
 {{<map}}
@@ Line 44: / Line 42: @@
 </WRAP>
-> Director: [[marco.crescenzi@iss.it|Marco Crescenzi]]
+> Director: [[franco.cardone@iss.it|Franco Cardone]]
-> ☎ **+39 06 4990 3163**
+> ☎ **+39 06 4990 3313**
+----
+\\
+[[https://www.corefacilitiesitalia.it|{{:nico-logo.png?150 |NICo Logo}}]] The ISS FAST Service adheres to the //**[[https://www.corefacilitiesitalia.it|Network Italiano Core Facilities]]**// (NICo) which was established in 2022 through a collaborative effort involving several [[https://www.corefacilitiesitalia.it/le-core-facilities/i-membri-di-nico|Italian Universities and Research Institutions]].
+NICo’s goal is to foster **positive synergies** among Core Facilities operating in the field of **Life Sciences** and to enhance their **visibility and accessibility**.
-/* > FIXME **To be revised by A.**\\ //(remove this paragraph once the translation is finished)// */
 \\
@@ Line 59: / Line 64: @@
 <WRAP centeralign>
-<wrap lo>October 23, 2024, 8:30 ~ 17:30</wrap>
+<wrap lo>October 23, 2024, Aula Marotta, 8:30 ~ 17:30</wrap>
 <wrap bigger>The role of Artificial Intelligence in diagnostic imaging</wrap>
-<wrap em>SAVE THE DATE</wrap> (more information to follow...)
+The objectives of the course are to update on the state of the art, the perspectives of AI in the different processes of acquisition and processing of images and its contribution to the diagnostic process and therapeutic follow-up. **[[en:eventi:2024:10:23:mri-ia|[read more...]]]**
 \\
-{{ :eventi:2024:10:23:20241023-ia-imaging-diag.png?300 |AI imaging for diagnostics poster}}
+{{ :eventi:2024:10:23:ia-imaging-diag.jpeg?300 |AI/diagnostics subject fantasy banner}}
 </WRAP>
+----
 <WRAP group> /* Begin of row */
@@ Line 230: / Line 237: @@
 <wrap bigger>**GENEVAX Project**</wrap>
-{{ :aree:fabiocell:genevax-loghi.png?350 |}}
+{{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}}
-In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]]
+In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]]
@@ Line 420: / Line 427: @@
 <WRAP centeralign>
-<wrap lo>October 23, 2024, 8:30 ~ 17:30</wrap>
+<wrap lo>October 23, 2024, Aula Marotta, 8:30 ~ 17:30</wrap>
 <wrap bigger>The role of Artificial Intelligence in diagnostic imaging</wrap>
-<wrap em>SAVE THE DATE</wrap> (more information to follow...)
+The objectives of the course are to update on the state of the art, the perspectives of AI in the different processes of acquisition and processing of images and its contribution to the diagnostic process and therapeutic follow-up. **[[en:eventi:2024:10:23:mri-ia|[read more...]]]**
 \\
-{{ :eventi:2024:10:23:20241023-ia-imaging-diag.png?300 |AI imaging for diagnostics poster}}
+{{ :eventi:2024:10:23:ia-imaging-diag.jpeg?300 |AI/diagnostics subject fantasy banner}}
 </WRAP>
@@ Line 585: / Line 592: @@
 <wrap bigger>**GENEVAX Project**</wrap>
-{{ :aree:fabiocell:genevax-loghi.png?350 |}}
+{{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}}
-In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]]
+In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]]
@@ Line 696: / Line 703: @@
 </ifinternet> /* END OF INTERNET VERSION "NEWS" */